» Articles » PMID: 9290362

Effectiveness of Hyaluronan on Corneal Epithelial Barrier Function in Dry Eye

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 1997 Jul 1
PMID 9290362
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/background: The aim of this study was to assess quantitatively the effectiveness of hyaluronan on corneal disruption in patients with dry eye. Corneal epithelial barrier function was evaluated by measuring fluorescein permeability using a slit-lamp fluorophotometer.

Methods: 11 patients with dry eye were assigned to this study. Hyaluronan ophthalmic solution (0.1% hyaluronic acid) was instilled five times a day to the right eye, in addition to the usual artificial tear solutions. The left eye received only the artificial tear solutions. Corneal barrier function was evaluated on the pretreatment day, and at 2 and 4 weeks after treatment. Fluorophotometry was used to measure fluorescein uptake at the central and lower corneal portions.

Results: Two weeks after treatment, hyaluronan treated right corneas showed significant corneal epithelial barrier improvement in the lower portion, compared with the pretreatment day (p < 0.025). Four weeks after treatment, the treated corneas showed significant improvement in the central corneal portion (p < 0.025) and improvement in the lower portion, compared with the pretreatment day. The untreated left corneas, on the other hand showed no improvement during the course of the study.

Conclusion: This study suggests that hyaluronan is effective in the treatment of corneal epithelial disruption in dry eye.

Citing Articles

Efficacy of 3% diquafosol long-acting eye drops in dry eye patients treated for three months.

Maehara H, Mukai R, Iitaka Y, Sekiryu T Jpn J Ophthalmol. 2024; 68(4):338-345.

PMID: 38795194 DOI: 10.1007/s10384-024-01069-z.


Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice.

Wang Y, Shi S, Zhang L, Wang S, Qin H, Wei Y Drug Deliv Transl Res. 2024; 15(1):171-184.

PMID: 38494558 DOI: 10.1007/s13346-024-01570-5.


Bone morphogenetic protein 4 thermosensitive hydrogel inhibits corneal neovascularization by repairing corneal epithelial apical junctional complexes.

Nan W, Shen S, Yang Y, Wu M, He Y, Zhang R Mater Today Bio. 2024; 24:100944.

PMID: 38269056 PMC: 10806348. DOI: 10.1016/j.mtbio.2024.100944.


A randomized multicenter evaluation of the efficacy of 0.15% hyaluronic acid versus 0.05% cyclosporine A in dry eye syndrome.

Lee J, Kim S, Lee H, Chung T, Kim J, Choi C Sci Rep. 2022; 12(1):18737.

PMID: 36333364 PMC: 9636392. DOI: 10.1038/s41598-022-21330-0.


Aqueous-Deficient Dry Eye Exacerbates Signs and Symptoms of Allergic Conjunctivitis in Mice.

Kishimoto T, Ishida W, Nakajima I, Fukuda K, Yamashiro K Int J Mol Sci. 2022; 23(9).

PMID: 35563309 PMC: 9099848. DOI: 10.3390/ijms23094918.


References
1.
van Bijsterveld O . Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969; 82(1):10-4. DOI: 10.1001/archopht.1969.00990020012003. View

2.
Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y . Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol. 1995; 79(11):1007-11. PMC: 505317. DOI: 10.1136/bjo.79.11.1007. View

3.
Lemp M . Artificial tear solutions. Int Ophthalmol Clin. 1973; 13(1):221-9. DOI: 10.1097/00004397-197301310-00016. View

4.
Lamberts D, Langston D, Chu W . A clinical study of slow-releasing artificial tears. Ophthalmology. 1978; 85(8):794-800. DOI: 10.1016/s0161-6420(78)35610-4. View

5.
Graue E, POLACK F, Balazs E . The protective effect of Na-hyaluronate to corneal endothelium. Exp Eye Res. 1980; 31(1):119-27. DOI: 10.1016/0014-4835(80)90094-9. View